Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Depreciation & Amortization (CF) (2024 - 2025)

Pasithea Therapeutics' (KTTAW) quarterly Depreciation & Amortization (CF) came in at $24000.0 in Q3 2025, up 380.0% year-over-year from $5000.0 in Q3 2024, and up 380.0% quarter-over-quarter from $5000.0 in Q3 2024.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Pasithea Therapeutics Corp. (KTTAW) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

Pasithea Therapeutics has disclosed Depreciation & Amortization (CF) across 2 years of filings, most recently posting $24000.0 for Q3 2025.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 24,000.00
Sep 30, 2024 5,000.00